178 related articles for article (PubMed ID: 30337253)
1. Treatment for Chronic Hepatitis C Prior to Total Hip Arthroplasty Significantly Reduces Periprosthetic Joint Infection.
Bedair HS; Schurko BM; Dwyer MK; Novikov D; Anoushiravani AA; Schwarzkopf R
J Arthroplasty; 2019 Jan; 34(1):132-135. PubMed ID: 30337253
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Treatment of Hepatitis C Is Associated With Lower Prosthetic Joint Infection Rates in US Veterans.
Bendich I; Takemoto S; Patterson JT; Monto A; Barber TC; Kuo AC
J Arthroplasty; 2019 Jul; 34(7S):S319-S326.e1. PubMed ID: 30930157
[TBL] [Abstract][Full Text] [Related]
3. Antiviral Treatment for Hepatitis C Is Associated With a Reduced Risk of Periprosthetic Joint Infection: A Meta-Analysis of Observational Studies.
Cheng T; Xu D; Yan Z; Ding C; Yang C; Zhang X
J Arthroplasty; 2022 Sep; 37(9):1870-1878. PubMed ID: 35483609
[TBL] [Abstract][Full Text] [Related]
4. Risk of Complications After THA Increases Among Patients Who Are Coinfected With HIV and Hepatitis C.
Mahure SA; Bosco JA; Slover JD; Vigdorchik J; Iorio R; Schwarzkopf R
Clin Orthop Relat Res; 2018 Feb; 476(2):356-369. PubMed ID: 29529669
[TBL] [Abstract][Full Text] [Related]
5. Racial Disparities in Treatment and Outcomes of Patients With Hepatitis C Undergoing Elective Total Joint Arthroplasty.
Howie CM; Cichos KH; Shoreibah MG; Jordan EM; Niknam KR; Chen AF; Hansen EN; McGwin GG; Ghanem ES
J Arthroplasty; 2024 Jul; 39(7):1671-1678. PubMed ID: 38331360
[TBL] [Abstract][Full Text] [Related]
6. Treating Hepatitis C Prior to Total Hip Arthroplasty is Cost-effective: A Markov Analysis.
Anoushiravani AA; Kalyanasundaram G; Feng JE; Congiusta F; Iorio R; DiCaprio MR
J Arthroplasty; 2023 Jul; 38(7 Suppl 2):S84-S90. PubMed ID: 36878438
[TBL] [Abstract][Full Text] [Related]
7. Does Preoperative Antiviral Treatment for Hepatitis C Decrease Risk of Complications After Total Hip Arthroplasty? A Matched Cohort Study.
Ross AJ; Ross BJ; Lee OC; Hood HW; Sanchez FL; Sherman WF
J Arthroplasty; 2022 Jul; 37(7):1326-1332.e3. PubMed ID: 35248753
[TBL] [Abstract][Full Text] [Related]
8. Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients.
Bozic KJ; Lau E; Kurtz S; Ong K; Rubash H; Vail TP; Berry DJ
J Bone Joint Surg Am; 2012 May; 94(9):794-800. PubMed ID: 22552668
[TBL] [Abstract][Full Text] [Related]
9. Closed incision negative pressure therapy decreases complications after periprosthetic fracture surgery around the hip and knee.
Cooper HJ; Roc GC; Bas MA; Berliner ZP; Hepinstall MS; Rodriguez JA; Weiner LS
Injury; 2018 Feb; 49(2):386-391. PubMed ID: 29174454
[TBL] [Abstract][Full Text] [Related]
10. Curtailing infection risks in hepatitis C patients: the effect of antiviral treatment in revision shoulder arthroplasty.
Hameed D; Shear B; Dubin J; Remily E; Bains SS; Chen Z; Mont MA; Hasan SA; Gilotra MN
J Shoulder Elbow Surg; 2024 Jul; 33(7):1528-1535. PubMed ID: 38104720
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of total hip arthroplasty in human immunodeficiency virus-positive patients.
Snir N; Wolfson TS; Schwarzkopf R; Swensen S; Alvarado CM; Hamula M; Dayan AJ
J Arthroplasty; 2014 Jan; 29(1):157-61. PubMed ID: 23683515
[TBL] [Abstract][Full Text] [Related]
12. The preoperative management of Hepatitis C may improve the outcome after total knee arthroplasty.
Schwarzkopf R; Novikov D; Anoushiravani AA; Feng JE; Vigdorchik J; Schurko B; Dwyer MK; Bedair HS
Bone Joint J; 2019 Jun; 101-B(6):667-674. PubMed ID: 31154838
[TBL] [Abstract][Full Text] [Related]
13. Preoperative Hip Injections Increase the Rate of Periprosthetic Infection After Total Hip Arthroplasty.
Schairer WW; Nwachukwu BU; Mayman DJ; Lyman S; Jerabek SA
J Arthroplasty; 2016 Sep; 31(9 Suppl):166-169.e1. PubMed ID: 27221820
[TBL] [Abstract][Full Text] [Related]
14. Short and Long-Term Postoperative Complications Following Total Joint Arthroplasty in Patients With Human Immunodeficiency Virus, Hepatitis B, or Hepatitis C.
Kildow BJ; Politzer CS; DiLallo M; Bolognesi MP; Seyler TM
J Arthroplasty; 2018 Jul; 33(7S):S86-S92.e1. PubMed ID: 29198873
[TBL] [Abstract][Full Text] [Related]
15. A Bundle Protocol to Reduce the Incidence of Periprosthetic Joint Infections After Total Joint Arthroplasty: A Single-Center Experience.
Bullock MW; Brown ML; Bracey DN; Langfitt MK; Shields JS; Lang JE
J Arthroplasty; 2017 Apr; 32(4):1067-1073. PubMed ID: 27956126
[TBL] [Abstract][Full Text] [Related]
16. Total Hip Arthroplasty After Acetabular Fracture Is Associated With Lower Survivorship and More Complications.
Morison Z; Moojen DJ; Nauth A; Hall J; McKee MD; Waddell JP; Schemitsch EH
Clin Orthop Relat Res; 2016 Feb; 474(2):392-8. PubMed ID: 26335343
[TBL] [Abstract][Full Text] [Related]
17. The Frank Stinchfield Award : Total Hip Arthroplasty for Femoral Neck Fracture Is Not a Typical DRG 470: A Propensity-matched Cohort Study.
Schairer WW; Lane JM; Halsey DA; Iorio R; Padgett DE; McLawhorn AS
Clin Orthop Relat Res; 2017 Feb; 475(2):353-360. PubMed ID: 27154530
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C Antiviral Treatment Decreases All-Cause Complications After Total Joint Arthroplasty Regardless of the Presence of Fibrosis.
Cornell E; Novikov D; Niu R; Staatz K; Schwarzkopf R; Smith EL
J Arthroplasty; 2021 May; 36(5):1551-1555. PubMed ID: 33431189
[TBL] [Abstract][Full Text] [Related]
19. Child-Pugh Class B or C Liver Disease Increases the Risk of Early Mortality in Patients With Hepatitis C Undergoing Elective Total Joint Arthroplasty Regardless of Treatment Status.
Cichos KH; Jordan E; Niknam K; Chen AF; Hansen EN; McGwin G; Ghanem ES
Clin Orthop Relat Res; 2023 Oct; 481(10):2016-2025. PubMed ID: 36961471
[TBL] [Abstract][Full Text] [Related]
20. Rate and Risk Factors for Periprosthetic Joint Infection Among 36,494 Primary Total Hip Arthroplasties.
Triantafyllopoulos GK; Soranoglou VG; Memtsoudis SG; Sculco TP; Poultsides LA
J Arthroplasty; 2018 Apr; 33(4):1166-1170. PubMed ID: 29248486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
